Literature DB >> 25408420

A stromal cell free culture system generates mouse pro-T cells that can reconstitute T-cell compartments in vivo.

Nadine Gehre1, Anja Nusser, Lilly von Muenchow, Roxane Tussiwand, Corinne Engdahl, Giuseppina Capoferri, Nabil Bosco, Rhodri Ceredig, Antonius G Rolink.   

Abstract

T-cell lymphopenia following BM transplantation or diseases such as AIDS result in immunodeficiency. Novel approaches to ameliorate this situation are urgently required. Herein, we describe a novel stromal cell free culture system in which Lineage(-) Sca1(+)c-kit(+) BM hematopoietic progenitors very efficiently differentiate into pro-T cells. This culture system consists of plate-bound Delta-like 4 Notch ligand and the cytokines SCF and IL-7. The pro-T cells developing in these cultures express CD25, CD117, and partially CD44; express cytoplasmic CD3ε; and have their TCRβ locus partially D-J rearranged. They could be expanded for over 3 months and used to reconstitute the T-cell compartments of sublethally irradiated T-cell-deficient CD3ε(-/-) mice or lethally irradiated WT mice. Pro-T cells generated in this system could partially correct the T-cell lymphopenia of pre-Tα(-/-) mice. However, reconstituted CD3ε(-/-) mice suffered from a wasting disease that was prevented by co-injection of purified CD4(+) CD25(high) WT Treg cells. In a T-cell-sufficient or T-lymphopenic setting, the development of disease was not observed. Thus, this in vitro culture system represents a powerful tool to generate large numbers of pro-T cells for transplantation and possibly with clinical applications.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  BM transplantation; Lymphopenia; Notch ligand Delta-like 4 (DL4); T-cell development; Treg cell

Mesh:

Substances:

Year:  2014        PMID: 25408420     DOI: 10.1002/eji.201444681

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL.

Authors:  Sandrine Degryse; Simon Bornschein; Charles E de Bock; Emilie Leroy; Marlies Vanden Bempt; Sofie Demeyer; Kris Jacobs; Ellen Geerdens; Olga Gielen; Jean Soulier; Christine J Harrison; Stefan N Constantinescu; Jan Cools
Journal:  Blood       Date:  2017-11-29       Impact factor: 22.113

2.  Progenitor T-cell differentiation from hematopoietic stem cells using Delta-like-4 and VCAM-1.

Authors:  Shreya Shukla; Matthew A Langley; Jastaranpreet Singh; John M Edgar; Mahmood Mohtashami; Juan Carlos Zúñiga-Pflücker; Peter W Zandstra
Journal:  Nat Methods       Date:  2017-04-10       Impact factor: 28.547

3.  Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development.

Authors:  Qing Wang; Ran Yan; Nancy Pinnell; Anna C McCarter; Yeonjoo Oh; Yiran Liu; Cher Sha; Noah F Garber; Yitong Chen; Qingqing Wu; Chia-Jui Ku; Ivy Tran; Amparo Serna Alarcon; Rork Kuick; James Douglas Engel; Ivan Maillard; Tomasz Cierpicki; Mark Y Chiang
Journal:  Blood       Date:  2018-08-03       Impact factor: 22.113

4.  Ribosomal Lesions Promote Oncogenic Mutagenesis.

Authors:  Sergey O Sulima; Kim R Kampen; Stijn Vereecke; Daniele Pepe; Laura Fancello; Jelle Verbeeck; Jonathan D Dinman; Kim De Keersmaecker
Journal:  Cancer Res       Date:  2018-11-27       Impact factor: 12.701

Review 5.  In Vitro T-Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One Destination.

Authors:  Michelle J Smith; Beau R Webber; Mahmood Mohtashami; Heather E Stefanski; Juan Carlos Zúñiga-Pflücker; Bruce R Blazar
Journal:  Stem Cells       Date:  2015-08-11       Impact factor: 6.277

6.  Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia.

Authors:  Michael Broux; Cristina Prieto; Sofie Demeyer; Marlies Vanden Bempt; Llucia Alberti-Servera; Inge Lodewijckx; Roel Vandepoel; Nicole Mentens; Olga Gielen; Kris Jacobs; Ellen Geerdens; Carmen Vicente; Charles E de Bock; Jan Cools
Journal:  Blood       Date:  2019-10-17       Impact factor: 22.113

Review 7.  Producing proT cells to promote immunotherapies.

Authors:  Jastaranpreet Singh; Juan Carlos Zúñiga-Pflücker
Journal:  Int Immunol       Date:  2018-11-14       Impact factor: 4.823

8.  DN2 Thymocytes Activate a Specific Robust DNA Damage Response to Ionizing Radiation-Induced DNA Double-Strand Breaks.

Authors:  Irene Calvo-Asensio; Tara Sugrue; Nabil Bosco; Antonius Rolink; Rhodri Ceredig
Journal:  Front Immunol       Date:  2018-06-11       Impact factor: 7.561

9.  Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.

Authors:  Quentin Van Thillo; Jolien De Bie; Janith A Seneviratne; Sofie Demeyer; Sofia Omari; Anushree Balachandran; Vicki Zhai; Wai L Tam; Bram Sweron; Ellen Geerdens; Olga Gielen; Sarah Provost; Heidi Segers; Nancy Boeckx; Glenn M Marshall; Belamy B Cheung; Kiyotaka Isobe; Itaru Kato; Junko Takita; Timothy G Amos; Ira W Deveson; Hannah McCalmont; Richard B Lock; Ethan P Oxley; Maximilian M Garwood; Ross A Dickins; Anne Uyttebroeck; Daniel R Carter; Jan Cools; Charles E de Bock
Journal:  Nat Commun       Date:  2021-07-06       Impact factor: 14.919

10.  Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system.

Authors:  S Bornschein; S Demeyer; R Stirparo; O Gielen; C Vicente; E Geerdens; B Ghesquière; S Aerts; J Cools; C E de Bock
Journal:  Leukemia       Date:  2017-11-20       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.